FDA Approves TRAMADOL HYDROCHLORIDE — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. received FDA approval to market the generic version of TRAMADOL HYDROCHLORIDE oral tablets, continuing the company's strategic push into the expansive opioid marketplace and intensifying generic competition for the widely utilized pain medication.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day